Placebo for NVR 3-778

DRUG2 trials

Sponsors

Novira Therapeutics, Inc.

Conditions

Chronic Hepatitis B

Phase 1

Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients

CompletedNCT02112799

Novira Therapeutics, Inc.Chronic Hepatitis B

Start: 2014-04-30End: 2016-05-18Updated: 2017-10-18

Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV Patients

CompletedNCT02401737

Novira Therapeutics, Inc.Chronic Hepatitis B

Start: 2015-01-31End: 2016-05-18Updated: 2017-10-18

Related Papers

Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV Infection.

2019-01-06111 citations